ESSEX INVESTMENT MANAGEMENT CO LLC - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 73 filers reported holding NEOS THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ESSEX INVESTMENT MANAGEMENT CO LLC ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$1,386,000
-5.2%
285,716
+22.1%
0.16%
-10.9%
Q2 2018$1,462,000
-24.6%
233,972
+0.1%
0.18%
-28.2%
Q1 2018$1,940,000
-22.9%
233,762
-5.2%
0.26%
-23.2%
Q4 2017$2,515,000
+15.4%
246,523
+3.5%
0.33%
+12.2%
Q3 2017$2,179,000
+55.6%
238,152
+24.2%
0.30%
+48.0%
Q2 2017$1,400,000191,7290.20%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,858,889$7,337,0005.11%
Proxima Capital Management, LLC 170,294$257,0000.77%
SPHERA FUNDS MANAGEMENT LTD. 3,530,731$5,331,0000.44%
Nantahala Capital Management 4,610,000$6,961,0000.21%
Wealthstar Advisors, LLC 73,295$111,0000.07%
Alambic Investment Management, L.P. 51,733$78,0000.06%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 100,000$151,0000.05%
BCS Wealth Management 29,520$45,0000.03%
Allred Capital Management, LLC 24,995$37,742,0000.02%
ALGERT GLOBAL LLC 34,254$52,0000.02%
View complete list of NEOS THERAPEUTICS INC shareholders